Skip to main content

Table 2 Correlation of BRAF mutation with clinicopathological parameters of papillary thyroid carcinomas

From: No evidence of association between human cytomegalovirus infection and papillary thyroid cancer

 

BRAF (+) (n = 31)

BRAF (-) (n = 9)

P value

Female

23 (74%)

5 (56%)

0.411

Age (years)

46 ± 15

40 ± 7

0.437

Hashimoto’s thyroiditis

4 (13%)

2 (22%)

0.602

Body mass index (kg/m2)

25.1 ± 4.2

22.8 ± 1.3

0.482

Body weight (kg)

62 ± 13

62 ± 1

0.725

Tumor size (cm)

3.1 ± 0.9

2.1 ± 1.2

0.045*

Extrathyroidal invasion

25 (81%)

3 (33%)

0.012*

Multifocality

11 (35%)

5 (56%)

0.441

Lymphovascular invasion

9 (29%)

2 (22%)

1.000

Lymph node metastasis

23 (74%)

2 (22%)

0.008*

TNM stage

  

0.044*

Stage 1

16 (52%)

8 (89%)

 

Stage 2

1 (3%)

0 (0%)

 

Stage 3

8 (26%)

1 (11%)

 

Stage 4

6 (19%)

0 (0%)

 
  1. * P value <0.05.